Dual-action therapies are gaining traction as a groundbreaking approach in the fight against both HIV and cancer. These treatments attack multiple pathways within infected cells, offering {a{ promise of improved efficacy and reduced side effects compared to traditional one-drug approaches. By combining different therapeutic modalities, dual-action